Join NPR’s David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer

GREENWICH, Conn., May 19 /PRNewswire/ — Helix Health, the first U.S. stand-alone genomic medicine practice, is hosting a 90-minute webcast this Wednesday, May 21, 2008 from 1:00-2:30 PM EDT examining:

How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer

To register, point your browser here http://event.netbriefings.com/event/helixhealth/register.html .

Every hour, 150 people in the United States are diagnosed with cancer. There is a growing number of people who are not willing to wait for that diagnosis. They are undergoing genetic testing to discover, and to know what they must do to manage these risks… personalized medicine for effective heath care management.

   Topics:     What should a doctor and patient do when a patient tests positive?     What is the risk in taking a “wait and see” approach?     Are there alternatives to radical surgery?     What are potential tort issues in predictive genetic testing and medical    uses of genetic tests?     Panel:     Steven A.R. Murphy, MD – Clinical Genetics Fellow at Yale School of    Medicine, and Helix Health’s Managing Partner will moderate the panel.     Barbara A. Ward, MD – Director, The Breast Center of Greenwich Hospital;    principal investigator of the STAR Trial    http://www.ynhh.org/healthlink/cancer/cancer_7_99.html; surgical    oncologist affiliated with Yale-New Haven Health System.     Jessica Queller – author of Pretty Is What Changes; television writer for    Felicity, The Gilmore Girls and One Tree Hill. Writer/producer on Gossip    Girl.     Jennifer Ibrahim, MD – clinical geneticist specializing in preconception    genetics as well as familial cancer syndromes.     David Ewing Duncan – bestselling author of Masterminds: Genius, DNA and    the Quest to Rewrite Life; Director, Center for Life Sciences Policy, UC    Berkeley; Chief Correspondent and co-host of National Public Radio’s    “Biotech Nation”.     Gary E. Marchant – Ph.D. J.D., Lincoln Professor of Emerging    Technologies, Law & Ethics, Sandra Day O’Connor College of Law; Executive    Director, Center for Law, Science & Technology, Professor, School of Life    Sciences Arizona State University.     Registration  

To register, point your browser here http://event.netbriefings.com/event/helixhealth/register.html

Registration is limited, so please register soon.

If you are unable to attend, a podcast of the session will soon be available on the Helix Health website. http://www.helixhealth.org/

About Helix Health, PLLC/LLC – a medical practice that is bringing genomic medicine to health care. With offices in Greenwich, CT and New York, NY, Helix Health offers patients and their physicians expertise in genomic medicine and provides the tools required to take full advantage of genetic testing.

Contact info@helixhealth.org for more information, or visit http://www.helixhealth.org/

Helix Health

CONTACT: Jonathan Freed, Chief Community Officer of Helix Health, PLLC,+1-888-584-8999, fax, +1-212-918-9394, webcasts@helixhealth.org

Web site: http://www.helixhealth.org/http://event.netbriefings.com/event/helixhealth/register.htmlhttp://www.ynhh.org/healthlink/cancer/cancer_7_99.html